Page 220 - Pagetit

6. CONCURRENT DISORDERS

Jaffe JH (1990) Drug addiction and drug abuse. In: Goodman AG et al., eds.
Goodman and Gilman’s pharmacological basis of therapeutics, 8th ed. New York,
NY, Pergamon Press:522–573.
Jarvik ME (1991) Beneficial effects of nicotine. British Journal of Addiction, 86:571–
575.
Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of
schizophrenia. American Journal of Psychiatry, 148:1301–1308.
Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine:
from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
Neuropsychopharmacology, 20:201–225.
Jibson MD, Tandon R (1998) New atypical antipsychotic medications. Journal of
Psychiatric Research, 32:215–228.
Jorenby DE et al. (1999) A controlled trial of sustained-release buproprion, a
nicotine patch, or both for smoking cessation. New England Journal of Medicine,
340:685–691.
Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor
stimulation in the ventral tegmental area and amygdala in behavioral
sensitization to cocaine. Journal of Pharmacology and Experimental Therapeutics,
267:486–495.
Kalivas PW, Duffy P (1998) Repeated cocaine administration alters extracellular
glutamate in the ventral tegmental area. Journal of Neurochemistry, 70:1497–1502.
Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorticolimbic
dopamine system by glutamic acid receptor subtypes. Journal of Pharmacology
and Experimental Therapeutics, 251:378–387.
Kapur S, Mann JJ (1992) Role of the dopaminergic system in depression. Biological
Psychiatry, 32:1–17.
Kapur S, Seeman P (2001) Does fast dissociation from the dopamine d(2) receptor
explain the action of atypical antipsychotics: a new hypothesis. American Journal
of Psychiatry, 158:360–369.
Kendler KS et al. (1993) Smoking and major depression: a causal analysis. Archives
of General Psychiatry, 50:36–43.
Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome.
Pharmacology, Biochemistry and Behavior, 70:531–549.
Kessler RC et al. (1994) Lifetime and 12-month prevalence of DSM-III-R
psychiatric disorders in the United States: results from the National Comorbidity
Survey. Archives of General Psychiatry, 51:8–19.
Kessler RC et al. (1996) The epidemiology of co-occurring addictive and mental
disorders: implications for prevention and service utilization. American Journal
of Orthopsychiatry, 66:17–31.
Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus
on heroin and cocaine dependence. American Journal of Psychiatry, 142:1259–
1264.
Khantzian EJ (1997) The self-medication hypothesis of substance use disorders:
a reconsideration and recent applications. Harvard Review of Psychiatry, 4:231–
244.

199

Chapter_6 199 19.1.2004, 11:49